Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Beam Therapeutics Inc., 3 years.
Beam Therapeutics Inc.
Director
Royalty Pharma plc
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Royalty Pharma plc June 4, 202699.9%
-
Beam Therapeutics Inc. June 4, 202599.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Royalty Pharma plc | Grant or award | +4,545 | — | — |
| Aug 13, 2025 | Denali Therapeutics Inc. | Open-market sale | −806 | $14.64 | $11,800 |
| Aug 12, 2025 | Denali Therapeutics Inc. | Open-market sale | −2,937 | $13.58 | $39,884 |
| Aug 5, 2025 | Denali Therapeutics Inc. | Option exercise | +44,655 | $0.68 | $30,365 |
| Jul 31, 2025 | Royalty Pharma plc | Grant or award | +2,752 | — | — |
| Jul 31, 2025 | Royalty Pharma plc | Grant or award | +5,806 | — | — |
| Jan 7, 2025 | Denali Therapeutics Inc. | Open-market sale | −2,907 | $20.81 | $60,495 |
| Jan 6, 2025 | Denali Therapeutics Inc. | Open-market sale | −12,255 | $20.22 | $247,796 |
| Jan 3, 2025 | Denali Therapeutics Inc. | Grant or award | +54,180 | — | — |
| Nov 25, 2024 | Denali Therapeutics Inc. | Option exercise | +17,845 | $0.68 | $12,135 |
| Aug 21, 2024 | Denali Therapeutics Inc. | Open-market sale | −14,098 | $24.41 | $344,132 |
| Aug 21, 2024 | Denali Therapeutics Inc. | Open-market sale | −5,907 | $24.96 | $147,439 |
| Aug 20, 2024 | Denali Therapeutics Inc. | Open-market sale | −2,453 | $23.79 | $58,357 |
| Aug 13, 2024 | Denali Therapeutics Inc. | Open-market sale | −2,337 | $22.89 | $53,494 |
| Feb 14, 2024 | Denali Therapeutics Inc. | Open-market sale | −1,405 | $17.79 | $24,995 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.